|
Part I.
Reference 1. Hernandez-Diaz, S., et al., Medications as a potential source of exposure to phthalates in the US population. Environ Health Perspect, 2009. 117(2): p. 185. 2.Philippat, C., et al., Exposure to phthalates and phenols during pregnancy and offspring size at birth. Environ Health Perspect, 2012. 120(3): p. 464. 3.Yolton, K., et al., Prenatal exposure to bisphenol A and phthalates and infant neurobehavior. Neurotoxicol Teratol, 2011. 33(5): p. 558-566. 4.Engel, S.M., et al., Prenatal phthalate exposure and performance on the Neonatal Behavioral Assessment Scale in a multiethnic birth cohort. Neurotoxicology, 2009. 30(4): p. 522-528. 5.Engel, S.M., et al., Prenatal phthalate exposure is associated with childhood behavior and executive functioning. Environ Health Perspect, 2010. 118(4): p. 565. 6.Whyatt, R.M., et al., Maternal prenatal urinary phthalate metabolite concentrations and child mental, psychomotor, and behavioral development at 3 years of age. Environ Health Perspect, 2012. 120(2): p. 290. 7.Borch, J., et al., Mechanisms underlying the anti-androgenic effects of diethylhexyl phthalate in fetal rat testis. Toxicology, 2006. 223(1): p. 144-155. 8.Xu, Y., et al., Di-(2-ethylhexyl)-phthalate affects lipid profiling in fetal rat brain upon maternal exposure. Arch Toxicol, 2007. 81(1): p. 57-62. 9.Kim, B.-N., et al., Phthalates exposure and attention-deficit/hyperactivity disorder in school-age children. Biological Psychiatry, 2009. 66(10): p. 958-963. 10.Cho, S.-C., et al., Relationship between environmental phthalate exposure and the intelligence of school-age children. Environ Health Perspect, 2010. 118(7): p. 1027. 11.Hsieh, C.-J., et al., The Taiwan Birth Panel Study: a prospective cohort study for environmentally-related child health. BMC Res Notes, 2011. 4(1): p. 291. 12.Wolff, M.S., et al., Prenatal phenol and phthalate exposures and birth outcomes. Environ Health Perspect, 2008. 116(8): p. 1092. 13.Ryan, J.J., L.A. Glass, and J.M. Bartels, Stability of the WISC-IV in a sample of elementary and middle school children. Appl Neuropsychol, 2010. 17(1): p. 68-72. 14.Kim, Y., et al., Prenatal exposure to phthalates and infant development at 6 months: prospective Mothers and Children’s Environmental Health (MOCEH) study. Environ Health Perspect, 2011. 119(10): p. 1495. 15.Hsieh, C.-J., et al., CYP1A1 Ile462Val and GSTT1 modify the effect of cord blood cotinine on neurodevelopment at 2 years of age. Neurotoxicology, 2008. 29(5): p. 839-845. 16.Miranda, M.L., et al., The relationship between early childhood blood lead levels and performance on end-of-grade tests. Environ Health Perspect, 2007. 115(8): p. 1242-7. 17.Kasper-Sonnenberg, M., et al., Levels of phthalate metabolites in urine among mother–child-pairs–Results from the Duisburg birth cohort study, Germany. Int J Hyg Environ Health, 2012. 215(3): p. 373-382.
18.Ferguson, K.K., R. Loch-Caruso, and J.D. Meeker, Urinary phthalate metabolites in relation to biomarkers of inflammation and oxidative stress: NHANES 1999–2006. Environ Res, 2011. 111(5): p. 718-726. 19.Hatch, E.E., et al., Association of urinary phthalate metabolite concentrations with body mass index and waist circumference: a cross-sectional study of NHANES data, 1999–2002. Environ Health, 2008. 7(27): p. 1-15. 20.Benowitz, N.L., Cotinine as a biomarker of environmental tobacco smoke exposure. Epidemiologic Reviews, 1996. 18(2): p. 188-204. 21.Huang, P.-C., et al., Childhood blood lead levels and intellectual development after ban of leaded gasoline in Taiwan: a 9-year prospective study. Environ Int, 2012. 40(1): p. 88-96. 22.Hauser, R., et al., Temporal variability of urinary phthalate metabolite levels in men of reproductive age. Environ Health Perspect, 2004. 112(17): p. 1734. 23.Hoppin, J.A., et al., Reproducibility of urinary phthalate metabolites in first morning urine samples. Environ Health Perspect, 2002. 110(5): p. 515. 24.Frederiksen, H., et al., Temporal Variability in Urinary Phthalate Metabolite Excretion Based on Spot, Morning, and 24-h Urine Samples: Considerations for Epidemiological Studies. Environ Sci Technol, 2012. 25.Frederiksen, H., N.E. Skakkebaek, and A.M. Andersson, Metabolism of phthalates in humans. Mol Nutr Food Res, 2007. 51(7): p. 899-911.
Part II. Reference 1.Johansson, N., A. Fredriksson, and P. Eriksson, Neonatal exposure to perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA) causes neurobehavioural defects in adult mice. Neurotoxicology, 2008. 29(1): p. 160-169. 2.Fei, C., et al., Prenatal exposure to perfluorooctanoate (PFOA) and perfluorooctane sulfonate (PFOS) and maternally reported developmental milestones in infancy. Environ Health Perspect, 2008. 116(10): p. 1391. 3.Hoffman, K., et al., Exposure to polyfluoroalkyl chemicals and attention deficit/hyperactivity disorder in US children 12–15 years of age. Environ Health Perspect, 2010. 118(12): p. 1762. 4.Hsieh, C.-J., et al., The Taiwan Birth Panel Study: a prospective cohort study for environmentally-related child health. BMC research notes, 2011. 4(1): p. 291. 5.Author, Achenbach T.(1991). Child behavior checklist/4-18. Burlington: University of Vermont, Retrieved from http://www.iprc.unc.edu/longscan/pages/measures/Ages12to14/writeups/Age%2012%20and%2014%20Child%20Behavior%20Checklist.pdf 6.Goodman, R., The Strengths and Difficulties Questionnaire: a research ote.Journal of child psychology and psychiatry, 1997. 38(5): p. 581-586. 7.Swanson, J.M., et al., Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment. Journal of the American Academy of Child & Adolescent Psychiatry, 2001. 40(2): p. 168-179. 8.Lien, G.-W., et al., Analysis of perfluorinated chemicals in umbilical cord blood by ultra-high performance liquid chromatography/tandem mass spectrometry. Journal of Chromatography B, 2011. 879(9): p. 641-646. 9.Gau, S.S.F., et al., Psychometric properties of the Chinese version of the Swanson, Nolan, and Pelham, version IV scale–parent form. Int J Methods Psychiatr Res, 2008. 17(1): p. 35-44. 10.Bussing, R., et al., Parent and Teacher SNAP-IV Ratings of Attention Deficit Hyperactivity Disorder Symptoms Psychometric Properties and Normative Ratings From a School District Sample. Assessment, 2008. 15(3): p. 317-328. 11.J, S., et al. Categorical and Dimensional Definitions and Evaluations of Symptoms of ADHD:The SNAP and he SWAN Ratings Scales. 2005. 12.CADDRA:SNAP-IV 26 -Teacher and Parent rating scale. Web site for CADDRA (http://caddra.ca/cms4/pdfs/caddraGuidelines2011SNAP.pdf) 13.CADDRA:SNAP-IV 26 RATING SCALE: SCORING INSTRUCTIONS. Web site for CADDRA (http://www.caddra.ca/cms4/pdfs/caddraGuidelines2011SNAP.pdf) 14.Kuo, P.-H., et al., A twin study of competence and behavioral/emotional problems among adolescents in Taiwan. Behavior Genetics, 2004. 34(1): p. 63-74. 15.Goodman, R., Psychometric properties of the strengths and difficulties questionnaire. Journal of the American Academy of Child & Adolescent Psychiatry, 2001. 40(11): p. 1337-1345. 16.Braun, J.M., et al., Exposures to environmental toxicants and attention deficit hyperactivity disorder in US children. Environ Health Perspect, 2006. 114(12): p. 1904. 17.Stein, C.R. and D.A. Savitz, Serum perfluorinated compound concentration and attention deficit/hyperactivity disorder in children 5–18 years of age. Environ Health Perspect, 2011. 119(10): p. 1466. 18.Fei, C. and J. Olsen, Prenatal exposure to perfluorinated chemicals and behavioral or coordination problems at age 7 years. Environ Health Perspect, 2011. 119(4): p. 573. 19.Butenhoff, J.L., et al., Gestational and lactational exposure to potassium perfluorooctanesulfonate (K+ PFOS) in rats: developmental neurotoxicity. Reproductive toxicology (Elmsford, NY), 2009. 27(3-4): p. 319. 20.Swanson, J.M., et al., Etiologic subtypes of attention-deficit/hyperactivity disorder: brain imaging, molecular genetic and environmental factors and the dopamine hypothesis. Neuropsychology review, 2007. 17(1): p. 39-59. 21.Johansson, N., P. Eriksson, and H. Viberg, Neonatal exposure to PFOS and PFOA in mice results in changes in proteins which are important for neuronal growth and synaptogenesis in the developing brain. Toxicological Sciences, 2009. 108(2): p. 412-418.
|